Literature DB >> 31552799

Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits?

Kathryn A Phillips1,2, Deborah A Marshall3, Allison W Kurian4.   

Abstract

Entities:  

Keywords:  economics; evidence-based medicine; precision medicine; preferences

Mesh：

Year:  2019        PMID： 31552799      PMCID： PMC6785357          DOI： 10.2217/pme-2019-0045

Source DB:  PubMed          Journal:  Per Med        ISSN： 1741-0541            Impact factor:   2.512


× No keyword cloud information.
  9 in total

1.  Is there a kink in consumers' threshold value for cost-effectiveness in health care?

Authors:  Bernie J O'Brien; Kirsten Gertsen; Andrew R Willan; Lisa A Faulkner
Journal:  Health Econ       Date:  2002-03       Impact factor: 3.046

2.  Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology.

Authors:  Susan Garfeld; Michael P Douglas; Karen V MacDonald; Deborah A Marshall; Kathryn A Phillips
Journal:  Per Med       Date:  2015-01-01       Impact factor: 2.512

3.  Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.

Authors:  Allison W Kurian; Irina Bondarenko; Reshma Jagsi; Christopher R Friese; M Chandler McLeod; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Timothy P Hofer; Steven J Katz
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

4.  Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.

Authors:  Y Bombard; L Rozmovits; M Trudeau; N B Leighl; K Deal; D A Marshall
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

5.  Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.

Authors:  Linyan Meng; Mohan Pammi; Anirudh Saronwala; Pilar Magoulas; Andrew Ray Ghazi; Francesco Vetrini; Jing Zhang; Weimin He; Avinash V Dharmadhikari; Chunjing Qu; Patricia Ward; Alicia Braxton; Swetha Narayanan; Xiaoyan Ge; Mari J Tokita; Teresa Santiago-Sim; Hongzheng Dai; Theodore Chiang; Hadley Smith; Mahshid S Azamian; Laurie Robak; Bret L Bostwick; Christian P Schaaf; Lorraine Potocki; Fernando Scaglia; Carlos A Bacino; Neil A Hanchard; Michael F Wangler; Daryl Scott; Chester Brown; Jianhong Hu; John W Belmont; Lindsay C Burrage; Brett H Graham; Vernon Reid Sutton; William J Craigen; Sharon E Plon; James R Lupski; Arthur L Beaudet; Richard A Gibbs; Donna M Muzny; Marcus J Miller; Xia Wang; Magalie S Leduc; Rui Xiao; Pengfei Liu; Chad Shaw; Magdalena Walkiewicz; Weimin Bi; Fan Xia; Brendan Lee; Christine M Eng; Yaping Yang; Seema R Lalani
Journal:  JAMA Pediatr       Date:  2017-12-04       Impact factor: 16.193

6.  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Matthew P Goetz; John A Olson; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter M Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; Jeffrey L Berenberg; Jeffrey Abrams; George W Sledge
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

7.  Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care.

Authors:  Kathryn A Phillips; David Schleifer; Carolin Hagelskamp
Journal:  Health Aff (Millwood)       Date:  2016-04       Impact factor: 6.301

8.  Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay.

Authors:  Michaela Tsai; Shelly Lo; William Audeh; Rubina Qamar; Raye Budway; Ellis Levine; Pat Whitworth; Blanche Mavromatis; Robin Zon; Dwight Oldham; Sarah Untch; Tina Treece; Lisa Blumencranz; Hatem Soliman
Journal:  JAMA Oncol       Date:  2018-01-11       Impact factor: 31.777

9.  How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.

Authors:  Deborah A Marshall; Ken Deal; Yvonne Bombard; Natasha Leighl; Karen V MacDonald; Maureen Trudeau
Journal:  BMJ Open       Date:  2016-06-02       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.